News Features Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too Michael O'Riordan December 09, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2019 Todd Neale October 31, 2019
News Conference News TCT 2019 Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA Todd Neale October 04, 2019
News Conference News TCT 2019 TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More Shelley Wood September 19, 2019
News Daily News MIDAS Touch: Anatomic Strategy Dramatically Lowers Pacemaker Rate With Evolut Valves Michael O'Riordan August 29, 2019
News Conference News ESC 2019 ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More Shelley Wood August 22, 2019
News Daily News Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data Caitlin E. Cox August 21, 2019
News Daily News No Volume-Outcome Link With Watchman for LAA Closure? Single-Center Study Michael O'Riordan August 19, 2019
News Conference News EuroPCR 2019 Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats Michael O'Riordan May 22, 2019
News Industry News Biosense Webster Announces Initial Results From First In-Human Study Of Novel High Power-Short Duration Ablation Catheter For Atrial Fibrillation May 09, 2019
News Industry News Intelligent Data Analytics Software Solution Comes To Electrophysiology With Launch Of Biosense Webster’s Cartonet May 07, 2019
News Industry News Biofourmis' RhythmAnalytics™ Platform Receives FDA Clearance for AI-Based Automated Interpretation of Cardiac Arrhythmias April 30, 2019
News Conference News ACC 2019 ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend Shelley Wood March 11, 2019
News Industry News First Atrial Fibrillation Patient Treated In Biosense Webster U.S. IDE Study Evaluating High Power, Short Duration Ablation Catheter February 04, 2019